Evaxion Biotech A/S
NASDAQ:EVAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evaxion Biotech A/S
NASDAQ:EVAX
|
DK |
|
Centrica PLC
F:CENN
|
UK |
|
Bukit Sembawang Estates Ltd
SGX:B61
|
SG |
|
O
|
Ordina NV
F:ORA
|
NL |
|
V
|
Vienna Insurance Group AG Wiener Versicherung Gruppe
F:WSV2
|
AT |
|
A
|
Actic Group AB
F:8XA
|
SE |
|
A
|
Amada Co Ltd
XBER:AA2
|
JP |
|
P
|
Pembina Pipeline Corp
F:P5P
|
CA |
Wall St Price Targets
EVAX Price Targets Summary
Evaxion Biotech A/S
According to Wall Street analysts, the average 1-year price target for
EVAX is 11.48 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EVAX's stock price target?
Price Target
11.48
USD
According to Wall Street analysts, the average 1-year price target for
EVAX is 11.48 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.
What is the Revenue forecast for Evaxion Biotech A/S?
Projected CAGR
62%
The compound annual growth rate for Revenue over the next 8 years is 62%.